STAT

MAY 17, 2023

Simply put, this occurs when a drug company combines two or more medicines in a package deal for health plans and pharmacy benefit managers, which determine lists of medicines that are covered by insurance. … In seeking to block Amgen from acquiring Horizon Therapeutics over concerns about monopolies, the U.S.

Insurance 92

Insurance Vaccines FDA Packaging 92

Pharmaceutical Technology

DECEMBER 15, 2023

Biovac has received an investment and advisory package from the IFC to support vaccine manufacturing and pandemic preparedness in Africa.

Vaccines 52

Vaccines Packaging 52

Pharmaceutical Technology

NOVEMBER 24, 2022

South African bio-pharmaceutical firm Biovac and the International Vaccine Institute (IVI) in South Korea have signed a licencing and technology transfer agreement for developing and manufacturing an oral cholera vaccine (OCV).

Vaccines 59

Vaccines Packaging 59

Pharmaceutical Technology

AUGUST 17, 2022

These programmes will include therapies and vaccines in infectious disease and oncology areas. These molecules synthesised newly are packaged densely into custom lipid nanoparticles (LNPs), which Orna has made to act on the body’s crucial tissues. We look forward to working with the talented scientific and technical teams at Orna.”.

Vaccines 59

Vaccines Research Laboratories Packaging 59

Roots Analysis

OCTOBER 30, 2023

The next generation RNA therapeutics and RNA vaccines pipeline currently features the presence of more than 20 circular RNA therapeutics and vaccines, being developed across initial stages of drug development (discovery and preclinical).

Vaccines 40

Vaccines Immunization Packaging Pharmaceutical Companies 40

Pharmaceutical Technology

SEPTEMBER 8, 2022

The list includes providers of development services, biologics management supply chain solutions, clinical trial services, commercial and logistics services, as well as packaging, labelling and distributing services for biologics.

Vaccines 40

Vaccines Packaging Documentation Labelling 40

Roots Analysis

FEBRUARY 1, 2024

Further, the cold chain storage process involves the cold chain storage, cold chain transportation, and monitoring temperature controlled packaging products. Therefore, the pharmaceutical, biotech, food and chemical industries usually rely on cold chain packaging for the transportation of their products.

Packaging 40

Packaging Documentation Vaccines 40

European Pharmaceutical Review

APRIL 25, 2024

Research on the global pharmaceutical parenteral packaging market by InsightAce Analytic Pvt. Regionally, North America is anticipated to hold a major portion of the pharmaceutical parenteral packaging market, according to the report. has predicted that the sector will value $18.85 billion by 2031. This is aligned with a CAGR of 4.47

Packaging 98

Packaging Generic Medicine Vaccines 98

STAT

OCTOBER 27, 2022

This calls for celebration with a cup of stimulation, and we are opening a new package of Pumpkin Spice for the occasion. However, this is also shaping up as a beautiful day as well, given the clear and sunny skies — and delicious breezes — enveloping the Pharmalot campus this morning. Autumn, after all, is in full swing.

Packaging 97

Packaging FDA Vaccines 97

European Pharmaceutical Review

DECEMBER 6, 2023

Elaborating on supply chain disruptions impacting sterile injectables, Venkatesh explains how the supply of e.g. packaging material and filters has not yet caught up demand following the pandemic. Packaging solutions for track and trace are becoming increasingly important and can be considered emerging trends.

Packaging 98

Packaging Vaccines 98

European Pharmaceutical Review

SEPTEMBER 22, 2023

According to a report by Research Nester, the global aseptic packaging market is projected to reach a revenue of $35 billion by 2033 and is estimated to reach a compound annual growth rate (CAGR) of 10 percent between 2023 and 2033. The post Aseptic packaging market to value $35bn by 2033 appeared first on European Pharmaceutical Review.

Packaging 105

Packaging Vaccines Compounding 105

STAT

AUGUST 7, 2024

In the pipeline are treatments that attempt to accomplish this by borrowing stealthing technologies from other fields, like gene therapy’s viral vector workhorse, AAV , or the lipid nanoparticles that coat RNA-interfering drugs and mRNA vaccines. Continue to STAT+ to read the full story…

Packaging 144

Packaging Immunization Vaccines 144

pharmaphorum

MAY 27, 2022

As we saw during the incredible response to the global COVID-19 pandemic, the industry demonstrated resilience and was able to rise to the challenge of an existential threat facing humanity and overcome incredible difficulties to develop and deploy lifesaving vaccines. About the interviewees.

Packaging 80

Packaging Generic Medicine Communication Hospitals 80

The Checkup by Singlecare

JULY 11, 2024

So, anyone taking it should avoid people who have highly infectious diseases like the flu or who recently received a live vaccine. So people with gout should avoid high fructose corn syrup, packaged foods, processed foods—anything that comes from a package.” High fructose burden can lead to worse gouts,” Dr. Downey says. “So

Dosage 94

Dosage Packaging Immunization FDA 94

Pharmaceutical Technology

DECEMBER 8, 2022

Forward-thinking suppliers, including packaging component providers, are also looking at how they can improve their processes through digital technologies. Tom Lenaerts is head of global process engineering for Datwyler, a leading supplier of parenteral packaging components such as stoppers and plungers. By Datwyler. United Kingdom.

Packaging 98

Packaging Vaccines Communication 98

European Pharmaceutical Review

MAY 29, 2023

Nanoparticle HIV vaccine shows potential in trial Nanomedicines generally require aseptic processing. described that while robotics is currently already widely used at the secondary packaging stage, the coming years will see large adoption of robots in aseptic manufacturing environments too. Tanzini et al.

Process Improvement 95

Process Improvement Packaging Vaccines FDA 95

Pharma Mirror

FEBRUARY 18, 2022

By Christopher Weikart, Chief Scientist, SiO2 Materials Science Even though drugs are meant to save lives, the primary packaging used for delivering drug therapies and vaccines may actually be putting us in danger. The post 7 Problems with Using Borosilicate Glass to Package Drugs appeared first on Pharma Mirror Magazine.

Packaging 52

Packaging Vaccines 52

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

STAT

JANUARY 24, 2024

government ministers are hoping to secure a major new vaccines investment by AstraZeneca with a possible state aid package worth tens of millions of dollars, in a deal that would deliver a big boost to the country’s life sciences sector , The Financial Times reports.

Packaging 97

Packaging Vaccines 97

Pharmaceutical Technology

AUGUST 16, 2022

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Outsourcing may also be pursued if it is more favourable in terms of time and/or cost.

Packaging 64

Packaging Vaccines FDA 64

pharmaphorum

JANUARY 28, 2021

The Covid-19 pandemic has put further pressure on clinical trial suppliers to be fleet of foot in getting products dispatched when a new patient is recruited, as studies for vaccines have been set up and run at unprecedented speed. . To find out more about the webinar and to register, visit [link] .

Labelling 52

Labelling Packaging Vaccines 52

Pharmaceutical Technology

NOVEMBER 30, 2022

These contracts involve the manufacturing of biological and small molecule active pharmaceutical ingredients (APIs), parenteral manufacturing and packaging, and other manufacturing-related tasks. Catalent has been engaged in the parenteral manufacturing and packaging of the anti-IL-4/IL-13 antibody. Regulatory decisions come in.

Packaging 52

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 1, 2022

Darwin is part of a package of projects and initiatives to transform to data-driven medicines regulation.”. This has included high-profile issues such as the study into reports of blood clots seen with AstraZeneca’s COVID-19 vaccine. Arlett explains that Darwin EU is playing a collaborative role in this goal.

Medical Records 111

Medical Records Packaging Vaccines 111

DiversifyRx

OCTOBER 20, 2022

When you communicate with the employer to have people sign up for a vaccine, have them simultaneously sign up for the at-home COVID tests. Their parents can pick up the tests from you and send them in their next care package. Here is a basic summary of all the best practices from people there. Maximize Offsite Flu Clinics.

Insurance 98

Insurance Packaging Documentation Communication 98

Pharmaceutical Technology

MARCH 21, 2023

Based on the individual contract, these CMOs manufacture small molecules or biological active pharmaceutical ingredients (APIs), as well as packaging material, and are charged with other related functions. Sharp Packaging Services is producing the solid dose of the drug and packaging it.

Packaging 59

Packaging FDA Vaccines Communication 59

ISPE

NOVEMBER 22, 2022

From aseptic manufacturing, process development, primary packaging selection to finished goods – you will be able to gain a lot more technical experiences by speaking to colleagues in the industry. Learn More & Register.

Compounding 98

Compounding Packaging Dosage Vaccines 98

pharmaphorum

APRIL 11, 2022

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. At Janssen, we strive to improve access to our innovative medicines and vaccines and achieve the best possible outcomes for patients across the world.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 115

pharmaphorum

JANUARY 17, 2022

SMi Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages. With interactive sessions, opportunities to question and learn, this workshop will discuss national IP rights and the trade of COVID 19 vaccines. Engage in interactive sessions about case law with a focus on packaging.

Packaging 52

Packaging Vaccines 52

DiversifyRx

SEPTEMBER 6, 2022

There are many examples of clinical revenue, such as MTMs, annual wellness visits, LTC consulting, food sensitivity testing, travel vaccines, and more. Just like they want their packages fast and efficiently, your patients want their healthcare fast and convenient and are willing to pay for it!

Independent Pharmacies 98

Independent Pharmacies Packaging Compounding Vaccines 98

European Pharmaceutical Review

NOVEMBER 14, 2023

In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass.

Packaging 105

Packaging Vaccines Documentation FDA 105

Roots Analysis

JANUARY 27, 2025

It is important to note that, for the purpose of subcutaneous biologics market analysis, the biologics were segregated into antibodies , nucleotides, proteins and vaccines. The below figure presents the distribution of subcutaneous biologics based on initial approval year and type of biologic.

Hospitals 40

Hospitals Packaging Compounding Immunization 40

pharmaphorum

JANUARY 27, 2023

The same goes for many commodities used in the production process for key medicines, from solvents through to packaging. The recent reversal of China’s “zero Covid” policy, at a time when the country still lacks optimal vaccine coverage, has also created another unknown, in terms of global supply and demand forecasting.

Packaging 105

Packaging Vaccines 105

pharmaphorum

NOVEMBER 27, 2022

It’s imperative that all suppliers and distributors know if disruption is likely to occur, whether that be concerning incoming raw materials or outgoing packaged drugs. Better communication with traceable data. Mix ups in hand-offs are another large disruptor, especially when drugs have specific shipping requirements.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

pharmaphorum

FEBRUARY 28, 2022

Explore how the industry is evolving with global developments including case studies of sustainable practices for drug delivery devices and the industry’s role in mass vaccination campaigns. Featured 2022 Speakers Include: Sriman Banerjee, Head of Packaging Development & Commercial Device Engineering, Takeda. Secondary packagers.

Packaging 52

Packaging Vaccines 52

European Pharmaceutical Review

OCTOBER 17, 2022

Historically, the 50-year-old site produced oral solids, sterile liquids, packaged products and offered retesting services to the Japanese and Asian markets. Both parties said they intend to use the facility as a platform for future growth and to ensure the site provides a reliable supply of affordable products.

Packaging 104

Packaging Pharmaceutical Companies Pharmaceutical Companies Vaccines 104

European Pharmaceutical Review

MARCH 7, 2024

On 4 March, ahead of the Spring Budget , the UK Chancellor of the Exchequer, Jeremy Hunt, announced a significant investment package for the UK life sciences and manufacturing sectors. The first portion of the investment comprises of £450 million to research, develop and manufacture vaccines at AstraZeneca’s facility in Speke, Liverpool.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Packaging Vaccines 98

European Pharmaceutical Review

MARCH 11, 2024

Additionally, this can be caused by “poor handling, repackaging, and nonadherence to good manufacturing practices [GMP] during dispensing and packaging have resulted in the microbiological contamination of non-sterile pharmaceutical products.” Ahmed et al.

Sterile Compounds 98

Sterile Compounds Compounding Packaging Pharmaceutical Companies 98